FDA warns over breast implant cancer risk after nine deaths confirmed

05:44 EST 8 Feb 2019 | Pharmafile

The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine patients have died as a result of this association since 2010.

There have been 457 unique cases breast implant-associated anaplastic large cell lymphoma confirmed by the US regulator out of 660 reports. Crucially, the disease linked to breast implants is not breast cancer but a form of non-Hodgkin’s lymphoma.

read more

Original Article: FDA warns over breast implant cancer risk after nine deaths confirmed

More From BioPortfolio on "FDA warns over breast implant cancer risk after nine deaths confirmed"